Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

A pilot study of a neuroscience-based, harm minimisation programme in schools and youth centres in Australia.

Debenham J, Birrell L, Champion K, Askovic M, Newton N.

BMJ Open. 2020 Feb 6;10(2):e033337. doi: 10.1136/bmjopen-2019-033337.

2.

Self-regulatory behaviour change techniques in interventions to promote healthy eating, physical activity, or weight loss: a meta-review.

Spring B, Champion KE, Acabchuk R, Hennessy EA.

Health Psychol Rev. 2020 Feb 17:1-32. doi: 10.1080/17437199.2020.1721310. [Epub ahead of print]

PMID:
31973666
3.

Preventing Substance Use Among Indigenous Adolescents in the USA, Canada, Australia and New Zealand: a Systematic Review of the Literature.

Snijder M, Stapinski L, Lees B, Ward J, Conrod P, Mushquash C, Belone L, Champion K, Chapman C, Teesson M, Newton N.

Prev Sci. 2020 Jan;21(1):65-85. doi: 10.1007/s11121-019-01038-w. Review.

4.

Data-driven discovery of coordinates and governing equations.

Champion K, Lusch B, Kutz JN, Brunton SL.

Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22445-22451. doi: 10.1073/pnas.1906995116. Epub 2019 Oct 21.

5.

Evaluating the differential effectiveness of social influence and personality-targeted alcohol prevention on mental health outcomes among high-risk youth: A novel cluster randomised controlled factorial design trial.

Newton NC, Stapinski L, Teesson M, Slade T, Champion KE, Barrett EL, Birrell L, Kelly E, Mather M, Conrod PJ.

Aust N Z J Psychiatry. 2020 Mar;54(3):259-271. doi: 10.1177/0004867419877948. Epub 2019 Sep 27.

PMID:
31561712
6.

Intravenous immunoglobulin efficacy for primary Sjögren's Syndrome associated small fiber neuropathy.

Gaillet A, Champion K, Lefaucheur JP, Trout H, Bergmann JF, Sène D.

Autoimmun Rev. 2019 Nov;18(11):102387. doi: 10.1016/j.autrev.2019.102387. Epub 2019 Sep 11. No abstract available.

PMID:
31520801
7.

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.

Ghorashian S, Kramer AM, Onuoha S, Wright G, Bartram J, Richardson R, Albon SJ, Casanovas-Company J, Castro F, Popova B, Villanueva K, Yeung J, Vetharoy W, Guvenel A, Wawrzyniecka PA, Mekkaoui L, Cheung GW, Pinner D, Chu J, Lucchini G, Silva J, Ciocarlie O, Lazareva A, Inglott S, Gilmour KC, Ahsan G, Ferrari M, Manzoor S, Champion K, Brooks T, Lopes A, Hackshaw A, Farzaneh F, Chiesa R, Rao K, Bonney D, Samarasinghe S, Goulden N, Vora A, Veys P, Hough R, Wynn R, Pule MA, Amrolia PJ.

Nat Med. 2019 Sep;25(9):1408-1414. doi: 10.1038/s41591-019-0549-5. Epub 2019 Sep 2.

PMID:
31477906
8.

A Novel Approach to Tackling Bullying in Schools: Personality-Targeted Intervention for Adolescent Victims and Bullies in Australia.

Kelly EV, Newton NC, Stapinski LA, Conrod PJ, Barrett EL, Champion KE, Teesson M.

J Am Acad Child Adolesc Psychiatry. 2020 Apr;59(4):508-518.e2. doi: 10.1016/j.jaac.2019.04.010. Epub 2019 Apr 30.

PMID:
31051243
9.

Lifestyle risk indices in adolescence and their relationships to adolescent disease burden: findings from an Australian national survey.

Mewton L, Champion K, Kay-Lambkin F, Sunderland M, Thornton L, Teesson M.

BMC Public Health. 2019 Jan 14;19(1):60. doi: 10.1186/s12889-019-6396-y.

10.

Perceptions of Health Behaviors and Mobile Health Applications in an Academically Elite College Population to Inform a Targeted Health Promotion Program.

Warnick JL, Pfammatter A, Champion K, Galluzzi T, Spring B.

Int J Behav Med. 2019 Apr;26(2):165-174. doi: 10.1007/s12529-018-09767-y.

PMID:
30632092
11.

A Mobile App to Provide Evidence-Based Information About Crystal Methamphetamine (Ice) to the Community (Cracks in the Ice): Co-Design and Beta Testing.

Birrell L, Deen H, Champion KE, Newton NC, Stapinski LA, Kay-Lambkin F, Teesson M, Chapman C.

JMIR Mhealth Uhealth. 2018 Dec 20;6(12):e11107. doi: 10.2196/11107.

12.
13.

Smartphone Apps About Crystal Methamphetamine ("Ice"): Systematic Search in App Stores and Assessment of Composition and Quality.

Chapman C, Champion KE, Birrell L, Deen H, Brierley ME, Stapinski LA, Kay-Lambkin F, Newton NC, Teesson M.

JMIR Mhealth Uhealth. 2018 Nov 21;6(11):e10442. doi: 10.2196/10442. Review.

14.

Universal cannabis outcomes from the Climate and Preventure (CAP) study: a cluster randomised controlled trial.

Newton NC, Teesson M, Mather M, Champion KE, Barrett EL, Stapinski L, Carragher N, Kelly E, Conrod PJ, Slade T.

Subst Abuse Treat Prev Policy. 2018 Sep 25;13(1):34. doi: 10.1186/s13011-018-0171-4.

15.

Climate schools plus: An online, combined student and parent, universal drug prevention program.

Thornton LK, Chapman C, Leidl D, Conroy C, Teesson M, Slade T, Koning I, Champion K, Stapinski L, Newton N.

Internet Interv. 2018 Mar 24;12:36-45. doi: 10.1016/j.invent.2018.03.007. eCollection 2018 Jun.

16.

Internet-Based Universal Prevention for Students and Parents to Prevent Alcohol and Cannabis Use Among Adolescents: Protocol for the Randomized Controlled Trial of Climate Schools Plus.

Newton NC, Chapman C, Slade T, Conroy C, Thornton L, Champion KE, Stapinski L, Koning I, Teesson M.

JMIR Res Protoc. 2018 Aug 17;7(8):e10849. doi: 10.2196/10849.

17.

Clustering of Multiple Risk Behaviors Among a Sample of 18-Year-Old Australians and Associations With Mental Health Outcomes: A Latent Class Analysis.

Champion KE, Mather M, Spring B, Kay-Lambkin F, Teesson M, Newton NC.

Front Public Health. 2018 May 7;6:135. doi: 10.3389/fpubh.2018.00135. eCollection 2018.

18.

Pathways to prevention: protocol for the CAP (Climate and Preventure) study to evaluate the long-term effectiveness of school-based universal, selective and combined alcohol misuse prevention into early adulthood.

Newton NC, Stapinski L, Slade T, Champion KE, Barrett EL, Chapman C, Smout A, Lawler S, Mather M, Castellanos-Ryan N, Conrod PJ, Teesson M.

BMC Public Health. 2018 May 21;18(1):643. doi: 10.1186/s12889-018-5554-y.

19.

A Web-Based Toolkit to Provide Evidence-Based Resources About Crystal Methamphetamine for the Australian Community: Collaborative Development of Cracks in the Ice.

Champion KE, Chapman C, Newton NC, Brierley ME, Stapinski L, Kay-Lambkin F, Nagle J, Teesson M.

JMIR Ment Health. 2018 Mar 20;5(1):e21. doi: 10.2196/mental.8891.

20.

Can anticoagulation therapy in cerebral venous thrombosis associated with Behçet's disease be stopped without relapse?

Roriz M, Crassard I, Lechtman S, Saadoun D, Champion K, Wechsler B, Chabriat H, Sène D.

Rev Neurol (Paris). 2018 Mar;174(3):162-166. doi: 10.1016/j.neurol.2017.06.021. Epub 2018 Mar 7.

PMID:
29523353
21.

Substance Use Prevention Programs for Indigenous Adolescents in the United States of America, Canada, Australia and New Zealand: Protocol for a Systematic Review.

Snijder M, Stapinski L, Lees B, Newton N, Champion K, Chapman C, Ward J, Teesson M.

JMIR Res Protoc. 2018 Feb 1;7(2):e38. doi: 10.2196/resprot.9012.

22.

A systematic review of school-based eHealth interventions targeting alcohol use, smoking, physical inactivity, diet, sedentary behaviour and sleep among adolescents: a review protocol.

Champion KE, Newton NC, Spring B, Wafford QE, Parmenter BJ, Teesson M.

Syst Rev. 2017 Dec 6;6(1):246. doi: 10.1186/s13643-017-0645-x.

23.

A systematic review of combined student- and parent-based programs to prevent alcohol and other drug use among adolescents.

Newton NC, Champion KE, Slade T, Chapman C, Stapinski L, Koning I, Tonks Z, Teesson M.

Drug Alcohol Rev. 2017 May;36(3):337-351. doi: 10.1111/dar.12497. Epub 2017 Mar 23. Review.

PMID:
28334456
24.

Combined universal and selective prevention for adolescent alcohol use: a cluster randomized controlled trial.

Teesson M, Newton NC, Slade T, Carragher N, Barrett EL, Champion KE, Kelly EV, Nair NK, Stapinski LA, Conrod PJ.

Psychol Med. 2017 Jul;47(10):1761-1770. doi: 10.1017/S0033291717000198. Epub 2017 Feb 22.

PMID:
28222825
25.

Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia.

Rossig C, Pule M, Altvater B, Saiagh S, Wright G, Ghorashian S, Clifton-Hadley L, Champion K, Sattar Z, Popova B, Hackshaw A, Smith P, Roberts T, Biagi E, Dreno B, Rousseau R, Kailayangiri S, Ahlmann M, Hough R, Kremens B, Sauer MG, Veys P, Goulden N, Cummins M, Amrolia PJ.

Leukemia. 2017 May;31(5):1087-1095. doi: 10.1038/leu.2017.39. Epub 2017 Jan 27.

PMID:
28126984
26.

Disrupted trabecular bone micro-architecture in middle-aged male HIV-infected treated patients.

Sellier P, Ostertag A, Collet C, Trout H, Champion K, Fernandez S, Lopes A, Morgand M, Clevenbergh P, Evans J, Souak S, de Vernejoul MC, Bergmann JF.

HIV Med. 2016 Aug;17(7):550-6. doi: 10.1111/hiv.12380. Epub 2016 May 17.

27.

Prevention of alcohol and other drug use and related harm in the digital age: what does the evidence tell us?

Champion KE, Newton NC, Teesson M.

Curr Opin Psychiatry. 2016 Jul;29(4):242-9. doi: 10.1097/YCO.0000000000000258. Review.

PMID:
27153124
28.

The long-term effectiveness of a selective, personality-targeted prevention program in reducing alcohol use and related harms: a cluster randomized controlled trial.

Newton NC, Conrod PJ, Slade T, Carragher N, Champion KE, Barrett EL, Kelly EV, Nair NK, Stapinski L, Teesson M.

J Child Psychol Psychiatry. 2016 Sep;57(9):1056-65. doi: 10.1111/jcpp.12558. Epub 2016 Apr 19.

PMID:
27090500
29.

Effectiveness of a universal internet-based prevention program for ecstasy and new psychoactive substances: a cluster randomized controlled trial.

Champion KE, Newton NC, Stapinski LA, Teesson M.

Addiction. 2016 Aug;111(8):1396-405. doi: 10.1111/add.13345. Epub 2016 Apr 13.

PMID:
26880476
30.

Etiologies and Management of Aseptic Meningitis in Patients Admitted to an Internal Medicine Department.

Jarrin I, Sellier P, Lopes A, Morgand M, Makovec T, Delcey V, Champion K, Simoneau G, Green A, Mouly S, Bergmann JF, Lloret-Linares C.

Medicine (Baltimore). 2016 Jan;95(2):e2372. doi: 10.1097/MD.0000000000002372.

31.

Effects of chronic low-dose exposure to ionizing radiation on physician microvascular structure revealed by nail fold capillaroscopy.

Wild P, Gauron C, Champion K, Cohen P, Menez C, Tellart AS, Thiel H, Grzebyk M, Pennarola R, Choudat D.

Radiat Environ Biophys. 2016 Mar;55(1):71-9. doi: 10.1007/s00411-015-0631-4. Epub 2015 Dec 28.

PMID:
26712038
32.

The structure of adolescent psychopathology: a symptom-level analysis.

Carragher N, Teesson M, Sunderland M, Newton NC, Krueger RF, Conrod PJ, Barrett EL, Champion KE, Nair NK, Slade T.

Psychol Med. 2016 Apr;46(5):981-94. doi: 10.1017/S0033291715002470. Epub 2015 Dec 1.

PMID:
26620582
33.

The validity of the Substance Use Risk Profile Scale (SURPS) among Australian adolescents.

Newton NC, Barrett EL, Castellanos-Ryan N, Kelly E, Champion KE, Stapinski L, Conrod PJ, Slade T, Nair N, Teesson M.

Addict Behav. 2016 Feb;53:23-30. doi: 10.1016/j.addbeh.2015.09.015. Epub 2015 Sep 25.

PMID:
26441044
34.

Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.

Champion KE, Teesson M, Newton NC.

Drug Alcohol Rev. 2016 May;35(3):338-44. doi: 10.1111/dar.12312. Epub 2015 Jul 21.

PMID:
26194894
35.

Microcystic Stromal Tumor of the Ovary: A Case Report of a Newly Described Ovarian Neoplasm With a β-catenin (CTNNB1) G34E Mutation.

Podduturi V, Tran T, Champion KJ, Onur N, Shiller SM.

Int J Gynecol Pathol. 2015 Nov;34(6):541-5. doi: 10.1097/PGP.0000000000000198.

PMID:
26107566
36.

Planning an Academic Clinical Trial.

Champion KM, Jones GR.

Methods Mol Biol. 2015;1317:287-313. doi: 10.1007/978-1-4939-2727-2_16. Review.

PMID:
26072413
37.

The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services.

Sherman K, Shaw LK, Champion K, Caldeira F, McCaskill M.

J Behav Med. 2015 Oct;38(5):706-14. doi: 10.1007/s10865-015-9630-9. Epub 2015 Mar 27.

PMID:
25813985
38.

A cross-validation trial of an Internet-based prevention program for alcohol and cannabis: Preliminary results from a cluster randomised controlled trial.

Champion KE, Newton NC, Stapinski L, Slade T, Barrett EL, Teesson M.

Aust N Z J Psychiatry. 2016 Jan;50(1):64-73. doi: 10.1177/0004867415577435. Epub 2015 Mar 23.

PMID:
25801662
39.

Endotoxin contamination of apolipoprotein A-I: effect on macrophage proliferation--a cautionary tale.

Jin X, Xu Q, Champion K, Kruth HS.

Atherosclerosis. 2015 May;240(1):121-4. doi: 10.1016/j.atherosclerosis.2015.03.007. Epub 2015 Mar 9.

40.

Randomized trial of DVD, telephone, and usual care for increasing mammography adherence.

Champion VL, Rawl SM, Bourff SA, Champion KM, Smith LG, Buchanan AH, Fish LJ, Monahan PO, Stump TE, Springston JK, Gathirua-Mwangi WG, Skinner CS.

J Health Psychol. 2016 Jun;21(6):916-26. doi: 10.1177/1359105314542817. Epub 2014 Jul 28.

41.

A universal harm-minimisation approach to preventing psychostimulant and cannabis use in adolescents: a cluster randomised controlled trial.

Vogl LE, Newton NC, Champion KE, Teesson M.

Subst Abuse Treat Prev Policy. 2014 Jun 18;9:24. doi: 10.1186/1747-597X-9-24.

42.

Universal Internet-based prevention for alcohol and cannabis use reduces truancy, psychological distress and moral disengagement: a cluster randomised controlled trial.

Newton NC, Andrews G, Champion KE, Teesson M.

Prev Med. 2014 Aug;65:109-15. doi: 10.1016/j.ypmed.2014.05.003. Epub 2014 May 10.

PMID:
24823906
43.

A cluster randomised controlled trial of the Climate Schools: Ecstasy and Emerging Drugs Module in Australian secondary schools: study protocol.

Champion KE, Teesson M, Newton NC.

BMC Public Health. 2013 Dec 12;13:1168. doi: 10.1186/1471-2458-13-1168.

44.

Optimizing the use of intravenous therapy in internal medicine.

Champion K, Mouly S, Lloret-Linares C, Lopes A, Vicaut E, Bergmann JF; PERMI Investigators Committee.

Am J Med. 2013 Oct;126(10):925.e1-9. doi: 10.1016/j.amjmed.2013.03.028. Epub 2013 Aug 3.

PMID:
23920107
45.

Unique cerebrovascular anomalies in Noonan syndrome with RAF1 mutation.

Zarate YA, Lichty AW, Champion KJ, Clarkson LK, Holden KR, Matheus MG.

J Child Neurol. 2014 Aug;29(8):NP13-7. doi: 10.1177/0883073813492384. Epub 2013 Jul 21.

PMID:
23877478
46.

Endotoxin neutralization as a biomonitor for inflammatory bowel disease.

Champion K, Chiu L, Ferbas J, Pepe M.

PLoS One. 2013 Jun 24;8(6):e67736. doi: 10.1371/journal.pone.0067736. Print 2013.

47.

Improving the limit of detection for Sanger sequencing: A comparison of methodologies for KRAS variant detection.

Davidson CJ, Zeringer E, Champion KJ, Gauthier MP, Wang F, Boonyaratanakornkit J, Jones JR, Schreiber E.

Biotechniques. 2012 Aug 14;53(3):182-188. doi: 10.2144/000113913.

PMID:
23083368
48.

A systematic review of school-based alcohol and other drug prevention programs facilitated by computers or the internet.

Champion KE, Newton NC, Barrett EL, Teesson M.

Drug Alcohol Rev. 2013 Mar;32(2):115-23. doi: 10.1111/j.1465-3362.2012.00517.x. Epub 2012 Oct 8. Review.

PMID:
23039085
49.

Improving the limit of detection for Sanger sequencing: a comparison of methodologies for KRAS variant detection.

Davidson CJ, Zeringer E, Champion KJ, Gauthier MP, Wang F, Boonyaratanakornkit J, Jones JR, Schreiber E.

Biotechniques. 2012 Sep;53(3):182-8. doi: 10.2144/000113913.

PMID:
22963480
50.

Efficacy of early clinical evaluation in predicting direct home discharge of elderly patients after hospitalization in internal medicine.

Gambier N, Simoneau G, Bihry N, Delcey V, Champion K, Sellier P, Jarrin I, Bergmann JF, Mouly S.

South Med J. 2012 Feb;105(2):63-7. doi: 10.1097/SMJ.0b013e318242d74d.

PMID:
22267091

Supplemental Content

Loading ...
Support Center